Showing results (61-70 of 1,349) with videos related to
Sort By:
Pageof 135
The World Allergy Organization Journal|November 29, 2023
The diagnostic workup for systemic mastocytosis differs from consensus recommendations: Results of a worldwide surveyPolina Pyatilova, Jonathan A Bernstein, Felix Aulenbacher, et al.The World Allergy Organization Journal|January 4, 2013
Diagnosis and treatment of urticaria and angioedema: a worldwide perspectiveMario Sánchez-Borges, Riccardo Asero, Ignacio J Ansotegui, et al.Clinical and Translational Allergy|January 31, 2025
Development of the symptomatic dermographism quality of life questionnaireMelba Muñoz, Nicole Schoepke, Sabine Altrichter, et al.Therapeutics and Clinical Risk Management|June 3, 2008
Treatment of atopic dermatitis with pimecrolimus - impact on quality of lifeHae-Hyuk Lee, Torsten Zuberbier, Margitta WormCurrent Opinion in Allergy and Clinical Immunology|August 5, 2016
A systematic review of the role of interleukin-17 and the interleukin-20 family in inflammatory allergic skin diseasesMaja A Hofmann, Felix Kiecker, Torsten ZuberbierJournal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 29, 2014
The allergic emergency--management of severe allergic reactionsAlexandra Werner-Busse, Torsten Zuberbier, Margitta WormCurrent Opinion in Allergy and Clinical Immunology|August 17, 2018
Noninvasive measures in atopic dermatitisJoachim W Fluhr, Torsten Zuberbier, Razvigor DarlenskiAllergologie Select|March 29, 2024
Individual wearable air purifier protects against pollen, house dust mite, and cat allergens: Report from an allergen exposure chamberKarl-Christian Bergmann, Teresa Hartung, Torsten ZuberbierAllergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 23, 2014
Risk of sensitization and allergy in Ragweed workers - a pilot studyOliver Brandt, Torsten Zuberbier, Karl-Christian BergmannAnti-Cancer Drugs|October 3, 2012
Celecoxib desensitization: continued temozolomide/celecoxib chemotherapy after a celecoxib-induced hypersensitivity reactionGuido J Burbach, Peter Vajkoczy, Torsten ZuberbierPageof 135